Literature DB >> 33718311

Objective Assessment of Physiologic Alterations Associated With Hemodynamically Significant Patent Ductus Arteriosus in Extremely Premature Neonates.

Aparna Patra1, Pratibha S Thakkar1, Majd Makhoul2, Henrietta S Bada1.   

Abstract

Delay in closure of ductus arteriosus in postnatal life may lead to serious consequences and complications in an extremely premature neonate secondary to hemodynamic alterations in regional blood flow pattern in various organs. Despite the widespread recognition amongst neonatologists to identify a hemodynamically significant patent ductus arteriosus (hsPDA) early in the postnatal course, there is lack of consensus in its definition and thus the threshold to initiate treatment. Echocardiographic assessment of PDA shunt size and volume combined with neonatologists' impression of clinical significance is most frequently used to determine the need for treatment of PDA. Common clinical signs of hsPDA utilized as surrogate for decreased tissue perfusion may lag behind early echocardiographic signs. Although echocardiogram allows direct assessment of PDA shunt and hemodynamic alterations in the heart, it is limited by dependence on pediatric cardiologist availability, interobserver variation and isolated time point assessment. Electrical cardiometry (EC) is a non-invasive continuous real time measurement of cardiac output by applying changes in thoracic electrical impedance. EC has been validated in preterm newborns by concomitant transthoracic echocardiogram assessments and may be beneficial in studying changes in cardiac output in premature newborns with hsPDA. Alterations in perfusion index derived from continuous pulse oximetry monitoring has been used to study changes in cardiac performance and tissue perfusion in infants with PDA. Near infrared spectroscopy (NIRS) has been used to objectively and continuously assess variations in renal, mesenteric, and cerebral oxygen saturation and thus perfusion changes due to diastolic vascular steal from hsPDA in preterm neonates. Doppler ultrasound studies measuring resistive indices in cerebral circulation indicate disturbance in cerebral perfusion secondary to ductal steal. With recent trends of change in practice toward less intervention in care of preterm newborn, treatment strategy needs to be targeted for select preterm population most vulnerable to adverse hemodynamic effects of PDA. Integration of these novel ways of hemodynamic and tissue perfusion assessment in routine clinical care may help mitigate the challenges in defining and targeting treatment of hsPDA thereby improving outcomes in extremely premature neonates.
Copyright © 2021 Patra, Thakkar, Makhoul and Bada.

Entities:  

Keywords:  echocardiogram; electrical cardiometry; hsPDA; near-infrared spectroscopy; physiologic; preterm

Year:  2021        PMID: 33718311      PMCID: PMC7946992          DOI: 10.3389/fped.2021.648584

Source DB:  PubMed          Journal:  Front Pediatr        ISSN: 2296-2360            Impact factor:   3.418


  110 in total

1.  Early echocardiographic prediction of ductal closure in neonates ≤ 30 weeks gestation.

Authors:  P P Thankavel; C R Rosenfeld; L Christie; C Ramaciotti
Journal:  J Perinatol       Date:  2012-04-12       Impact factor: 2.521

2.  Use of tissue oxygenation index and fractional tissue oxygen extraction as non-invasive parameters for cerebral oxygenation. A validation study in piglets.

Authors:  Gunnar Naulaers; Bart Meyns; Marc Miserez; Veerle Leunens; Sabine Van Huffel; Paul Casaer; Michael Weindling; Hugo Devlieger
Journal:  Neonatology       Date:  2007-03-23       Impact factor: 4.035

Review 3.  Neonatal hemodynamics: monitoring, data acquisition and analysis.

Authors:  Sadaf Soleymani; Matthew Borzage; Shahab Noori; Istvan Seri
Journal:  Expert Rev Med Devices       Date:  2012-09       Impact factor: 3.166

4.  Short-term outcome of very-low-birthweight infants with arterial hypotension in the first 24 h of life.

Authors:  Kirstin Faust; Christoph Härtel; Michael Preuß; Heike Rabe; Claudia Roll; Michael Emeis; Christian Wieg; Miklos Szabo; Egbert Herting; Wolfgang Göpel
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2015-07-21       Impact factor: 5.747

5.  Perfusion index in the very preterm infant.

Authors:  Meredith Kinoshita; Colin Patrick Hawkes; C Anthony Ryan; Eugene Michael Dempsey
Journal:  Acta Paediatr       Date:  2013-09       Impact factor: 2.299

6.  Reference Ranges for Cerebral Tissue Oxygen Saturation Index in Term Neonates during Immediate Neonatal Transition after Birth.

Authors:  Nariae Baik; Berndt Urlesberger; Bernhard Schwaberger; Georg M Schmölzer; Lukas Mileder; Alexander Avian; Gerhard Pichler
Journal:  Neonatology       Date:  2015-09-01       Impact factor: 4.035

7.  Noninvasive peripheral perfusion index as a possible tool for screening for critical left heart obstruction.

Authors:  A de-Wahl Granelli; I Ostman-Smith
Journal:  Acta Paediatr       Date:  2007-08-28       Impact factor: 2.299

8.  Comparison of electrical velocimetry and thermodilution techniques for the measurement of cardiac output.

Authors:  N Zoremba; J Bickenbach; B Krauss; R Rossaint; R Kuhlen; G Schälte
Journal:  Acta Anaesthesiol Scand       Date:  2007-11       Impact factor: 2.105

Review 9.  Treating hypotension in the preterm infant: when and with what: a critical and systematic review.

Authors:  E M Dempsey; K J Barrington
Journal:  J Perinatol       Date:  2007-08       Impact factor: 2.521

10.  The perfusion index derived from a pulse oximeter for predicting low superior vena cava flow in very low birth weight infants.

Authors:  S Takahashi; S Kakiuchi; Y Nanba; K Tsukamoto; T Nakamura; Y Ito
Journal:  J Perinatol       Date:  2009-11-12       Impact factor: 2.521

View more
  1 in total

1.  An Update on Patent Ductus Arteriosus and What is Coming Next.

Authors:  Ömer Erdeve; Emel Okulu; Yogen Singh; Richard Sindelar; Mehmet Yekta Oncel; Gianluca Terrin; Giovanni Boscarino; Ali Bülbül; Hannes Sallmon; Begüm Atasay; Fahri Ovalı; Ronald I Clyman
Journal:  Turk Arch Pediatr       Date:  2022-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.